NGS of immunoglobulin and T-cell receptor genes repertoire for minimal residual disease diagnostics in pediatric acute lymphoblastic leukemia

被引:0
|
作者
Miroshnichenkova, A. [1 ]
Komkov, A. [1 ,2 ]
Zerkalenkova, E. [1 ]
Popov, A. [1 ]
Nugmanov, G. [2 ]
Mamedov, I. [2 ]
Olshanskaya, Y. [1 ]
Maschan, M. [1 ]
机构
[1] Dmitry Rogachev Natl Res Ctr Pediat Hematol Oncol, Moscow, Russia
[2] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia
基金
俄罗斯科学基金会;
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
E-P07.12
引用
收藏
页码:939 / 940
页数:2
相关论文
共 50 条
  • [41] High-Throughput Sequencing of T-Cell Receptor Gene Loci for Minimal Residual Disease Monitoring in T Lymphoblastic Leukemia
    Wu, David
    Sherwood, Anna
    Winter, Stuart S.
    Dunsmore, Kimberly
    Loh, Mignon L.
    Fromm, Jonathan R.
    Greisman, Harvey A.
    Sabath, Daniel E.
    Wood, Brent L.
    Robins, Harlan
    BLOOD, 2011, 118 (21) : 1092 - 1092
  • [42] REARRANGEMENT OF IMMUNOGLOBULIN HEAVY-CHAIN GENES IN T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA
    KITCHINGMAN, GR
    ROVIGATTI, U
    MAUER, AM
    MELVIN, S
    MURPHY, SB
    STASS, S
    BLOOD, 1985, 65 (03) : 725 - 729
  • [43] DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE LYMPHOBLASTIC-LEUKEMIA BY INVITRO AMPLIFICATION OF REARRANGED T-CELL RECEPTOR DELTA-CHAIN SEQUENCES
    HANSENHAGGE, TE
    YOKOTA, S
    BARTRAM, CR
    BLOOD, 1989, 74 (05) : 1762 - 1767
  • [44] Unusual feature of the T-cell receptor genes in T-lineage acute lymphoblastic leukemia
    Yamanaka, K
    Kubo, K
    Kiyoi, H
    Ichihashi, T
    Kato, K
    Horibe, K
    Naoe, T
    LEUKEMIA RESEARCH, 1997, 21 (07) : 667 - 674
  • [45] Absolute Lymphocyte Count at the End of Induction as a Surrogate Marker for Minimal Residual Disease in T-cell Acute Lymphoblastic Leukemia
    Pushpam, Deepam
    Chopra, Anita
    Sreenivas, Vishnubhatla
    Kumar, Rajive
    Bakhshi, Sameer
    INDIAN PEDIATRICS, 2019, 56 (05) : 381 - 383
  • [46] Absolute Lymphocyte Count at the End of Induction as a Surrogate Marker for Minimal Residual Disease in T-cell Acute Lymphoblastic Leukemia
    Deepam Pushpam
    Anita Chopra
    Vishnubhatla Sreenivas
    Rajive Kumar
    Sameer Bakhshi
    Indian Pediatrics, 2019, 56 : 381 - 383
  • [47] TFDP3 confers chemoresistance in minimal residual disease within childhood T-cell acute lymphoblastic leukemia
    Chu, Ming
    Yin, Kailin
    Dong, Yujun
    Wang, Pingzhang
    Xue, Yun
    Zhou, Peng
    Wang, Yuqi
    Wang, Yuedan
    ONCOTARGET, 2017, 8 (01) : 1405 - 1415
  • [48] Role of Minimal Residual Disease Monitoring in Adult and Pediatric Acute Lymphoblastic Leukemia
    Campana, Dario
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2009, 23 (05) : 1083 - +
  • [49] Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia
    Modvig, S.
    Madsen, H. O.
    Siitonen, S. M.
    Rosthoj, S.
    Tierens, A.
    Juvonen, V
    Osnes, L. T. N.
    Valerhaugen, H.
    Hultdin, M.
    Thorn, I
    Matuzeviciene, R.
    Stoskus, M.
    Marincevic, M.
    Fogelstrand, L.
    Lilleorg, A.
    Toft, N.
    Jonsson, O. G.
    Pruunsild, K.
    Vaitkeviciene, G.
    Vettenranta, K.
    Lund, B.
    Abrahamsson, J.
    Schmiegelow, K.
    Marquart, H., V
    LEUKEMIA, 2019, 33 (06) : 1324 - 1336
  • [50] Application of minimal residual disease monitoring in pediatric patients with acute lymphoblastic leukemia
    Qin, X.
    Zhang, M-Y
    Liu, W-J
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (20) : 6885 - 6895